東北大学

東北大学大学院医学系研究科
腎臓内科学分野
東北大学病院　腎臓・高血圧内科

論文・著書

～歴史ある論文・著書～

2022年

論文【英文】

  1. Uemura S, Kegasa Y, Tada K, Tsukahara T, Kabayama S, YamamotoT, Miyazaki M, Takada J, Nakayama M. Impact of hemodialysis solutions containing different levels of molecular hydrogen (H2) on the patient-reported outcome of fatigue. Renal Replacement Therapy volume 8, Article number: 32 (2022)
  2. Watanabe K, Sato E, Mishima E, Miyazaki M, Tanaka T. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances. Int J Mol Sci. 2022 Dec 29;24(1):570. doi: 10.3390/ijms24010570.
  3. Ohyama-Tamagake A, Kaneko K, Itami R, Nakano M, Namioka Y, Izumi R, Sato H, Suzuki H, Takeda A, Okazaki Y, Yatsuka Y, Abe T, Murayama K, Sugeno N, Misu T, Aoki M. Adult-onset Leigh Syndrome with a m.9176 T>C Mutation Manifested as Reversible Cerebral Vasoconstriction Syndrome. Intern Med. 2022 Dec 21. doi: 10.2169/internalmedicine.0773-22.
  4. Hara A, Wada T, Muso E, Maruyama S, Kato S, Furuichi K, Yoshimura K, Toyama T, Sakai N, Suzuki H, Tsukamoto T, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Goto S, Sakamaki Y, Yokoyama H, Mori N, Tanaka S, Yuzawa Y, Hasegawa M, Matsubara T, Wada J, Tanabe K, Masutani K, Abe Y, Tsuruya K, Fujimoto S, Iwatsubo S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Sofue T, Miyata H, Nakano T, Ohtake T, Kobayashi S; LICENSE study group. Effect of Low-Density Lipoprotein Apheresis on Quality of Life in Patients with Diabetes, Proteinuria, and Hypercholesterolemia. Blood Purif. 2022 Dec 15:1-9. doi: 10.1159/000527900.
  5. Ishii T, Mimura I, Nagaoka K, Naito A, Sugasawa T, Kuroda R, Yamada D, Kanki Y, Kume H, Ushiku T, Kakimi K, Tanaka T, Nangaku M. Effect of M2-like macrophages of the injured-kidney cortex on kidney cancer progression. Cell Death Discov. 2022 Dec 5;8(1):480. doi: 10.1038/s41420-022-01255-3.
  6. Saeki T, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Yamaguchi Y, Saito T, Nakashima H, Kawano M. Comparison of clinicopathological features between patients with and without hypocomplementemia in IgG4-related kidney disease. Nephrol Dial Transplant. 2022 Dec 1:gfac317. doi: 10.1093/ndt/gfac317.
  7. Akiyama Y, Takenaka Y, Kasahara T, Abe T, Tomioka Y, Ivanov P. RTCB Complex Regulates Stress-Induced tRNA Cleavage. Int J Mol Sci. 2022 Oct 28;23(21):13100. doi: 10.3390/ijms232113100.
  8. Oe Y, Takahashi N. Tissue Factor, Thrombosis, and Chronic Kidney Disease. Biomedicines. 2022 Oct 28;10(11):2737. doi: 10.3390/biomedicines10112737.
  9. Terui H, Yamasaki K, Wada-Irimada M, Onodera-Amagai M, Hatchome N, Mizuashi M, Yamashita R, Kawabe T, Ishii N, Abe T, Asano Y, Aiba S. Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis. Sci Immunol. 2022 Oct 28;7(76):eabm9811. doi: 10.1126/sciimmunol.abm9811. Epub 2022 Oct 28.
  10. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Uchida S, Tsukamoto T, Tsuruya K, Akai Y, Nitta K, Fukunaga M, Hayashi H, Shoji T, Masutani K, Konta T, Katafuchi R, Nishio S, Wada T, Goto S, Tamai H, Shirasaki A, Nagai K, Nishino T, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Sofue T, Fujimoto S, Mizutani M, Naruse T, Hiramatsu T, Morozumi K, Sobajima H, Saka Y, Ishimura E, Ito T, Ichikawa D, Shigematsu T, Sato H, Narita I, Yoshitaka I; Japan Nephrotic Syndrome Cohort Study investigators. Acute Kidney Injury and Remission of Proteinuria in Minimal Change Disease. Kidney Int Rep. 2022 Aug 5;7(10):2283-2288. doi: 10.1016/j.ekir.2022.07.173. eCollection 2022 Oct.
  11. Ishigaki S, Oe Y, Omata K, Ono Y, Tezuka Y, Morimoto R, Watanabe S, Nishioka H, Satoh F, Yoshida M, Makino R, Okamoto K, Nagasawa T, Inoshita N, Yamada S, Sato H, Ito S, Miyazaki M. Marked reduction of proteinuria after removal of a growth hormone-producing pituitary adenoma in a patient with focal segmental glomerulosclerosis: a case report and literature review. CEN Case Rep. 2022 Oct 6. doi: 10.1007/s13730-022-00739-6.
  12. Itagaki K, Notsuda H, Suzuki T, Tanaka R, Kamada H, Omata K, Tezuka Y, Ota H, Okada Y, Saiki Y. Combined left thoracoscopic and median sternotomy approach to resect aortopulmonary mediastinal paraganglioma following feeding artery embolization: a case report. Surg Case Rep. 2022 Sep 23;8(1):176. doi: 10.1186/s40792-022-01534-2.
  13. Williams TA, Gong S, Tsurutani Y, Tezuka Y, Thuzar M, Burrello J, Wu VC, Yamazaki Y, Mulatero P, Sasano H, Stowasser M, Nishikawa T, Satoh F, Reincke M. Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study. Lancet Diabetes Endocrinol. 2022 Nov;10(11):769-771. doi: 10.1016/S2213-8587(22)00253-4. Epub 2022 Sep 19.
  14. Wu X, Nagasawa S, Muto K, Ueda M, Suzuki C, Abe T, Higashitani A. Mitochonic Acid 5 Improves Duchenne Muscular Dystrophy and Parkinson's Disease Model of Caenorhabditis elegans. Int J Mol Sci. 2022 Aug 24;23(17):9572. doi: 10.3390/ijms23179572.
  15. Sugahara M, Tanaka T, Nangaku M. Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors. Pharmacol Ther. 2022 Nov;239:108272. doi: 10.1016/j.pharmthera.2022.108272. Epub 2022 Aug 27.
  16. Matsuki T, Hirose T, Ohsaki Y, Shimada S, Endo A, Ito H, Takahashi C, Yamakoshi S, Oba-Yabana I, Anan G, Kato T, Tajima R, Nakayama S, Kimura T, Nakamura H, Tani J, Takahashi K, Kure S, Mori T. Inhibition of platelet-derived growth factor pathway suppresses tubulointerstitial injury in renal congestion. J Hypertens. 2022 Oct 1;40(10):1935-1949. doi: 10.1097/HJH.0000000000003191. Epub 2022 Aug 19.
  17. Oguro S, Morimoto R, Seiji K, Ota H, Kinoshita T, Kawabata M, Ono Y, Omata K, Tezuka Y, Satoh F, Ito S, Moriya N, Matsui S, Nishikawa T, Omura M, Nakai K, Nakatsuka S, Kurihara I, Miyashita K, Koda W, Minami T, Takeda Y, Kometani M, Oki Y, Oishi T, Ushio T, Goshima S, Takase K. Safety and feasibility of radiofrequency ablation using bipolar electrodes for aldosterone-producing adenoma: a multicentric prospective clinical study. Sci Rep. 2022 Aug 18;12(1):14090. doi: 10.1038/s41598-022-18136-5.
  18. Kimura T, Yamamoto R, Yoshino M, Sakate R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Nagai K, Yamagata K, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Mimura T, Suzuki S, Saka Y, Sofue T, Kitagawa K, Fujita Y, Mizutani M, Kashihara N, Sato H, Narita I, Isaka Y. Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2022 Dec;26(12):1170-1179. doi: 10.1007/s10157-022-02256-3. Epub 2022 Aug 12.
  19. Yamauchi M, Sato T, Otake A, Kumondai M, Sato Y, Kikuchi M, Maekawa M, Yamaguchi H, Abe T, Mano N. Bile Acid-Drug Interaction via Organic Anion-Transporting Polypeptide 4C1 Is a Potential Mechanism of Altered Pharmacokinetics of Renally Excreted Drugs. Int J Mol Sci. 2022 Jul 31;23(15):8508. doi: 10.3390/ijms23158508.
  20. Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, Tonnus W, Nepachalovich P, Eggenhofer E, Aldrovandi M, Henkelmann B, Yamada KI, Wanninger J, Zilka O, Sato E, Feederle R, Hass D, Maida A, Mourão ASD, Linkermann A, Geissler EK, Nakagawa K, Abe T, Fedorova M, Proneth B, Pratt DA, Conrad M. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022 Aug;608(7924):778-783. doi: 10.1038/s41586-022-05022-3. Epub 2022 Aug 3.
  21. Ido K, Miyazaki M, Nakayama M. Hemodialysis Record Sharing: Solution for Work Burden Reduction and Disaster Preparedness. JMIR Form Res. 2022 Jul 22;6(7):e32925. doi: 10.2196/32925.
  22. Ishida T, Inoue T, Niizuma K, Inoue T, Sasaki K, Sakata H, Ezura M, Uenohara H, Abe T, Tominaga T. Plasma tRNA derivatives concentrations for detecting early brain damage in patients with acute large vessel occlusion and predicting clinical outcomes after endovascular thrombectomy. Clin Neurol Neurosurg. 2022 Sep;220:107358. doi: 10.1016/j.clineuro.2022.107358. Epub 2022 Jul 1.
  23. Kambayashi Y, Ohuchi K, Chiba H, Tamabuchi E, Nagasawa T, Asano Y, Fujimura T. Tubulointerstitial Nephritis in an Advanced Melanoma Patient Treated with Encorafenib plus Binimetinib Combination Therapy. Case Rep Oncol. 2022 May 2;15(2):469-472. doi: 10.1159/000524013. eCollection 2022 May-Aug.
  24. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Uchida S, Tsukamoto T, Tsuruya K, Akai Y, Nitta K, Fukunaga M, Hayashi H, Masutani K, Wada T, Konta T, Katafuchi R, Nishio S, Goto S, Tamai H, Shirasaki A, Shoji T, Nagai K, Nishino T, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Mizutani M, Naruse T, Hiramatsu T, Morozumi K, Sobajima H, Saka Y, Ishimura E, Ichikawa D, Shigematsu T, Sofue T, Fujimoto S, Ito T, Sato H, Narita I, Isaka Y; JNSCS Investigators. Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study. Sci Rep. 2022 Jun 13;12(1):9782. doi: 10.1038/s41598-022-13067-7.
  25. Watanabe H, Fujishima F, Inokura K, Makino R, Daikoku K, Sasaki R, Ichinohasama R, Sato H, Joh K, Sasano H. Rapidly progressive glomerulonephritis in a patient with angioimmunoblastic T-cell lymphoma: a rare autopsy case showing IgA vasculitis and cylinder-like deposits. Med Mol Morphol. 2022 Sep;55(3):267-273. doi: 10.1007/s00795-022-00325-w. Epub 2022 Jun 3.
  26. Mishima E, Conrad M. Nutritional and Metabolic Control of Ferroptosis. Annu Rev Nutr. 2022 Aug 22;42:275-309. doi: 10.1146/annurev-nutr-062320-114541. Epub 2022 Jun 1.
  27. Sakakibara H, Seiji K, Oguro S, Mori K, Omata K, Tezuka Y, Ono Y, Morimoto R, Masuda T, Miyamoto H, Hirao T, Niwa Y, Suzuki Y, Baba Y, Satoh F, Takase K. Transvenous Radiofrequency Ablation of Adrenal Gland: Experimental Study. Cardiovasc Intervent Radiol. 2022 Aug;45(8):1178-1185. doi: 10.1007/s00270-022-03155-6. Epub 2022 May 23.
  28. Harashima S, Yamazaki Y, Motomura N, Ono Y, Omata K, Tezuka Y, Morimoto R, Nakamura Y, Satoh F, Suzuki H, Kwon GE, Choi MH, Sasano H. Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism. J Steroid Biochem Mol Biol. 2022 Jul;221:106116. doi: 10.1016/j.jsbmb.2022.106116. Epub 2022 May 6.
  29. Tezuka Y, Ito S. The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers. Curr Hypertens Rep. 2022 Jul;24(7):215-224. doi: 10.1007/s11906-022-01177-6. Epub 2022 Apr 30.
  30. Yokoyama A, Suzuki S, Okamoto K, Sugawara A. The physiological and pathophysiological roles of carbohydrate response element binding protein in the kidney. Endocr J. 2022 Jun 28;69(6):605-612. doi: 10.1507/endocrj.EJ22-0083. Epub 2022 Apr 26.
  31. Todoriki S, Hosoda Y, Yamamoto T, Watanabe M, Sekimoto A, Sato H, Mori T, Miyazaki M, Takahashi N, Sato E. Methylglyoxal Induces Inflammation, Metabolic Modulation and Oxidative Stress in Myoblast Cells. Toxins (Basel). 2022 Apr 7;14(4):263. doi: 10.3390/toxins14040263.
  32. Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022 Apr 28;69(4):327-359. doi: 10.1507/endocrj.EJ21-0508. Epub 2022 Apr 12.
  33. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Tsukamoto T, Uchida S, Tsuruya K, Shoji T, Hayashi H, Akai Y, Fukunaga M, Konta T, Nishio S, Goto S, Tamai H, Nagai K, Katafuchi R, Masutani K, Wada T, Nishino T, Shirasaki A, Sobajima H, Nitta K, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Mizutani M, Akahori T, Naruse T, Hiramatsu T, Morozumi K, Mimura T, Saka Y, Ishimura E, Hasegawa H, Ichikawa D, Shigematsu T, Sato H, Narita I, Isaka Y; Japan Nephrotic Syndrome Cohort Study investigators. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study. J Nephrol. 2022 May;35(4):1135-1144. doi: 10.1007/s40620-022-01279-z. Epub 2022 Apr 2.
  34. Maruno S, Tanaka T, Nangaku M. Exploring molecular targets in diabetic kidney disease. Kidney Res Clin Pract. 2022 Sep;41(Suppl 2):S33-S45. doi: 10.23876/j.krcp.21.251. Epub 2022 Mar 15.
  35. Akiyama Y, Lyons SM, Fay MM, Tomioka Y, Abe T, Anderson PJ, Ivanov P. Selective Cleavage at CCA Ends and Anticodon Loops of tRNAs by Stress-Induced RNases. Front Mol Biosci. 2022 Mar 1;9:791094. doi: 10.3389/fmolb.2022.791094. eCollection 2022.
  36. Konta Y, Saito E, Sato K, Furuta K, Miyauchi K, Furukawa A, Sato H, Yamamoto T. Tubulointerstitial Nephritis after Using a Sodium-glucose Cotransporter 2 Inhibitor: A Case Report. Intern Med. 2022 Nov 1;61(21):3239-3243. doi: 10.2169/internalmedicine.9011-21. Epub 2022 Mar 12.
  37. Kataoka H, Mochizuki T, Ohara M, Tsuruta Y, Iwasa N, Yoshida R, Tsuchiya K, Nitta K, Kimura K, Hosoya T; FEATHER Investigators. Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study. Sci Rep. 2022 Mar 8;12(1):3784. doi: 10.1038/s41598-022-07737-9.
  38. Kitagawa K, Arima H, Yamamoto Y, Ueda S, Rakugi H, Kohro T, Yonemoto K, Matsumoto M, Saruta T, Shimada K; Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group. Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysis. Hypertens Res. 2022 Apr;45(4):591-601. doi: 10.1038/s41440-022-00862-y. Epub 2022 Mar 4.
  39. Motomura N, Yamazaki Y, Koga D, Harashima S, Gao X, Tezuka Y, Omata K, Ono Y, Morimoto R, Satoh F, Nakamura Y, Kwon GE, Choi MH, Ito A, Sasano H. The Association of Cholesterol Uptake and Synthesis with Histology and Genotype in Cortisol-Producing Adenoma (CPA). Int J Mol Sci. 2022 Feb 16;23(4):2174. doi: 10.3390/ijms23042174.
  40. Mishima E, Abe T. Gut Microbiota Dynamics and Uremic Toxins. Toxins (Basel). 2022 Feb 17;14(2):146. doi: 10.3390/toxins14020146.
  41. Shikata K, Ito S, Kashihara N, Nangaku M, Wada T, Okuda Y, Sawanobori T, Sugimoto K. Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS-3150) and sodium-glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies. J Diabetes Investig. 2022 Jul;13(7):1190-1202. doi: 10.1111/jdi.13778. Epub 2022 Apr 21.
  42. Ishii T, Tanaka T, Nangaku M. Is HIF activation Janus faced? The therapeutic effects of the HIF-2α inhibitor. Kidney Int. 2022 May;101(5):866-869. doi: 10.1016/j.kint.2022.01.023. Epub 2022 Feb 12.
  43. Kagaya-Takeuchi S, Nagasawa T, Takeuchi Y, Takeda K, Joh K, Miyazaki M. Concomitant pleuritis and pericarditis developing during glucocorticoid therapy: a case report on granulomatosis with polyangiitis. CEN Case Rep. 2022 Aug;11(3):371-375. doi: 10.1007/s13730-021-00678-8. Epub 2022 Feb 2.
  44. Motomura N, Yamazaki Y, Gao X, Tezuka Y, Omata K, Ono Y, Morimoto R, Satoh F, Nakamura Y, Shim J, Choi MH, Ito A, Sasano H. Visualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA). J Steroid Biochem Mol Biol. 2022 Apr;218:106062. doi: 10.1016/j.jsbmb.2022.106062. Epub 2022 Jan 12.
  45. Oikawa D, Yamashita S, Takahashi S, Waki T, Kikuchi K, Abe T, Katayama T, Nakayama T. (+)-Sesamin, a sesame lignan, is a potent inhibitor of gut bacterial tryptophan indole-lyase that is a key enzyme in chronic kidney disease pathogenesis. Biochem Biophys Res Commun. 2022 Jan 29;590:158-162. doi: 10.1016/j.bbrc.2021.12.088. Epub 2021 Dec 26.
  46. Mishima E. The E2F1-IREB2 axis regulates neuronal ferroptosis in cerebral ischemia. Hypertens Res. 2022 Jun;45(6):1085-1086. doi: 10.1038/s41440-021-00837-5. Epub 2021 Dec 24.
  47. Mishima E, Abe T. Role of the microbiota in hypertension and antihypertensive drug metabolism. Hypertens Res. 2022 Feb;45(2):246-253. doi: 10.1038/s41440-021-00804-0. Epub 2021 Dec 9.
  48. Rossi GP, Crimì F, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Kool LS, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Wu VC, Kratka Z, Barbiero G, Battistel M, Seccia TM. Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism. Hypertension. 2022 Jan;79(1):187-195. doi: 10.1161/HYPERTENSIONAHA.121.18284. Epub 2021 Nov 17.
  49. Kario K, Ito S, Itoh H, Rakugi H, Okuda Y, Yamakawa S. Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes. Hypertens Res. 2022 Jan;45(1):97-105. doi: 10.1038/s41440-021-00756-5. Epub 2021 Oct 15.
  50. Abe M, Akaishi T, Ishizawa K, Shinano H, Ohtomo H, Orikasa K, Takayama S, Masaura A, Miyazaki M, Abe T, Yokota K, Ishii T. A massive natural disaster, the Great East Japan Earthquake, and the incidence of dialysis due to end-stage kidney disease. J Nephrol. 2022 Apr;35(3):719-724. doi: 10.1007/s40620-021-01140-9. Epub 2021 Oct 12.
  51. Inoue H, Torigoe K, Torigoe M, Muta K, Obata Y, Suzuki T, Suzuki C, Abe T, Koji T, Mukae H, Nishino T. Mitochonic acid-5 ameliorates chlorhexidine gluconate-induced peritoneal fibrosis in mice. Med Mol Morphol. 2022 Mar;55(1):27-40. doi: 10.1007/s00795-021-00305-6. Epub 2021 Oct 7.
  52. Asayama K, Ohkubo T, Rakugi H, Miyakawa M, Mori H, Katsuya T, Ikehara Y, Ueda S, Ohya Y, Tsuchihashi T, Kario K, Miura K, Ito S, Umemura S; Japanese Society of Hypertension Working Group on the COmparison of Self-measured home, Automated unattended office, Conventional attended office blood pressure (COSAC) study. Direct comparison of the reproducibility of in-office and self-measured home blood pressures. J Hypertens. 2022 Feb 1;40(2):398-407. doi: 10.1097/HJH.0000000000003026.
  53. Hashimoto J, Tagawa K, Westerhof BE, Ito S. Central-to-peripheral stiffness gradients determine diastolic pressure and flow fluctuation waveforms: time domain analysis of femoral artery pulse. J Hypertens. 2022 Feb 1;40(2):338-347. doi: 10.1097/HJH.0000000000003014.
  54. Nishikawa T, Satoh F, Takashi Y, Yanase T, Itoh H, Kurihara I, Shibata H, Oki Y, Naruse M, Sasamoto H, Kuwa K. Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood. Endocr J. 2022 Jan 28;69(1):45-54. doi: 10.1507/endocrj.EJ21-0278. Epub 2021 Jul 22.
  55. Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Margill SB, Shafigullina Z, Quinkler M, Oliveras A, Lee BC, Wu VC, Kratka Z, Seccia TM, Lenzini L. Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study. Eur J Prev Cardiol. 2022 Mar 11;29(2):e85-e93. doi: 10.1093/eurjpc/zwaa108.

論文【邦文】

  1. 石岡広崇、田中哲洋：【尿細管と腎線維化】線維化を誘導する尿細管障害　尿細管虚血と腎線維化；腎と透析 93巻6号 845-849
  2. 宮崎真理子：慢性腎臓病(CKD)の進行抑制と心血管イベント防止の戦略；秋田腎不全研究会誌25巻 15-21
  3. 田中哲洋：【腎臓症候群(第3版)-その他の腎臓疾患を含めて-[IV]】保存期腎不全　腎性貧血；日本臨床 別冊腎臓症候群IV 15-18
  4. 三島英換、菊地晃一、阿部高明：腎臓病と腸内細菌叢　最近の話題を中心に；腎臓内科 16巻4号 477-482
  5. 石井太祐、田中哲洋：【腎疾患における臨床研究の進歩】基礎研究と臨床研究の融合　腎臓低酸素応答；腎と透析 93巻3号 347-352
  6. 田中哲洋：コロナ第6波と第7波のはざまでの学会参加；腎と透析 93巻3号 297-298
  7. 三島英換：【腎臓症候群(第3版)-その他の腎臓疾患を含めて-】先天性・遺伝性腎疾患　先天代謝異常　Lesch-Nyhan症候群；日本臨床 別冊腎臓症候群II 66-68
  8. 大黒顕佑、尾股慧、手塚雄太、小野美澄、森本玲、白井剛志、宮崎真理子、張替秀郎、佐藤文俊：今月の症例　自己免疫性膵炎に対するステロイド維持療法中にIgG4関連下垂体炎を発症した1例；日本内科学会雑誌 111巻8号 1588-1593
  9. 柳垣聡、小黒草太、清治和将、高瀬圭、尾股慧、手塚雄太、小野美澄、森本玲、田中哲洋、佐藤文俊：【アルドステロンをめぐる臨床課題】原発性アルドステロン症治療におけるラジオ波治療の意義；糖尿病・内分泌代謝科 55巻2号 204-209
  10. 豊原敬文、阿部高明、田中哲洋：【腎臓症候群(第3版)-その他の腎臓疾患を含めて-[I]】腎血管系障害　腎動脈線維筋性異形成；日本臨床 別冊腎臓症候群I 221-225
  11. 倉田遊、田中哲洋、菅原真衣：【腎性貧血:HIF-PH阻害薬への期待と課題】HIFと糖尿病性腎臓病；腎と透析 93巻2号 265-269
  12. 鈴木健弘、佐藤恵美子、阿部高明：【腎疾患におけるサルコペニア・フレイルの病態と臨床】慢性腎臓病におけるサルコペニア・フレイルの発症機序-尿毒素、腸内細菌環境悪化、慢性炎症とミトコンドリア機能不全；腎臓内科 16巻1号 22-30
  13. 藤岡正樹、福井健人、田中哲洋：エナロデュスタットの肝臓におけるエリスロポエチン産生への影響；腎と透析 93巻1号 135-140
  14. 佐藤恵美子：サルコペニア・フレイルと尿毒素吸着薬；腎臓内科 16巻1号 94-99
  15. 安倍寛子、田中哲洋：【慢性腎臓病(CKD)一歩進んだ日常診療マネジメント】日常臨床に求められる腎臓病の新しい知識　腎性貧血治療の展開；Medical Practice 39巻6号 812-820
  16. 藤倉恵美、宮崎真理子：被災者・支援者への精神的ケア　透析治療の特殊性を踏まえた対応；日本急性血液浄化学会雑誌 13巻1号 35-41
  17. 大江佑治、宮崎真理子：【腎代替療法のすべて】(第9章)透析患者の合併症　透析患者の低血圧；腎と透析 92巻増刊 476-478
  18. 豊原敬文、Chad A Cowan、阿部高明：糖尿病患者由来のiPS細胞を用いた動脈硬化抑制因子の発見；糖尿病・内分泌代謝科 54巻6号 768-775
  19. 安倍寛子、田中哲洋：【新しい心不全薬のすべて】【SGLT2阻害薬のすべて】SGLT2阻害薬を用いた腎臓病に関する大規模臨床試験；循環器内科 91巻6号 694-700
  20. 田中哲洋、南学正臣：【低酸素生物学の新展開】低酸素応答と腎性貧血治療；細胞 54巻7号 360-363
  21. 阿部高明：ミトコンドリア病 - 病態解明を基盤とした治療薬開発；医学のあゆみ 281巻12号 1119-1119
  22. 長澤将：【腎性貧血の診断と薬剤選択、治療目標】；日本医事新報 5116号 18-27
  23. 宮崎真理子：宮城県における新型コロナウイルス感染症の現況；宮城県腎不全研究会会誌 49回 48-55
  24. 倉田遊、田中哲洋、菅原真衣：HIFと糖尿病性腎臓病；糖尿病・内分泌代謝科 54巻5号 601-608
  25. 菊地晃一、阿部高明：【便秘と慢性腎臓病・透析医療】便秘,腸内細菌叢,長期予後；臨床透析 38巻4号 357-365
  26. 豊原敬文、阿部高明：【こんなときどうする?他科とのコミュニケーションガイド】(第8章)腎臓内科・泌尿器科　高血圧；産科と婦人科 89巻Suppl. 330-335
  27. 菊地晃一、阿部高明：環境と腎臓"の質問にお答えします　腸内細菌は全身の臓器にいろいろな影響を与えるといわれていますが、腎臓に対してはどうでしょうか?"；腎臓 44巻 44-46
  28. 宮崎真理子：慢性腎臓病；日本内科学会雑誌 111巻3号 526-531
  29. 三島英換：腸内環境をターゲットした慢性腎臓病の病態解明と新規治療法の開発；日本応用酵素協会誌 56号 99
  30. 山崎智貴, 田中哲洋, 三村維真理：【心腎連関から新薬まで!心×腎疾患の薬物治療】心腎領域の新薬　HIF-PH阻害薬　腎性貧血；薬事 64巻4号 768-773
  31. 宮崎真理子、渡邊崇、山本多恵、山口裕二、杉浦章、中道崇、森建文、竹内和久、宮城県新型コロナウイルス感染症医療調整本部：【コロナ禍における腎不全診療の現状と展望】新型コロナウイルスと血液透析　透析患者の受け入れとネットワーク　各地域での取り組み　宮城県での取り組み；日本透析医学会雑誌 55巻2号 93-97
  32. 長澤将：新規薬剤と電解質異常　低Na血症におけるAVP V2受容体阻害薬vaptanの役割；腎臓内科 15巻2号 212-218
  33. 菊地晃一、阿部高明：糖尿病性腎臓病と腸内細菌叢；腎臓内科 15巻1号 124-130
  34. 阿部高明：慢性腎臓病と腸内環境；日本腎臓リハビリテーション学会誌 1巻1号 81-96

著書【編集・監修・単独執筆】

  1. 長澤将：この局面にこの一手! Dr.長澤直伝! 腎臓病患者マネジメントの定跡；金芳堂 2022年4月
  2. 長澤将：Dr.長澤の腎問答；中外医学社 2022年6月
  3. 長澤将：長澤先生、腎臓って結局どう診ればいいですか？〜適切な判断のための診療センスが身につき、食事・薬物療法からコンサルトまで自信をもってできるようになる；羊土社 2022年9月
TOP